Predicting Parkinson’s progression

GNS' AI predicts progression of PD

A team from GNS Healthcare Inc. and the University of Rochester has demonstrated that two SNPs may be able to predict how quickly Parkinson’s disease patients will progress. The results could help personalize medical care and select more homogeneous patient populations for clinical trials.

Early diagnosis and prediction of Parkinson’s disease are still key challenges in the disease, largely because the molecular drivers are complex and still poorly understood.

In a September

Read the full 721 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers